Prospera Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$229K Sell
1,806
-643
-26% -$81.4K ﹤0.01% 1218
2025
Q1
$313K Sell
2,449
-284
-10% -$36.3K 0.01% 974
2024
Q4
$361K Sell
2,733
-147
-5% -$19.4K 0.01% 857
2024
Q3
$419K Buy
2,880
+152
+6% +$22.1K 0.01% 782
2024
Q2
$374K Sell
2,728
-482
-15% -$66.2K 0.01% 824
2024
Q1
$440K Buy
3,210
+428
+15% +$58.7K 0.01% 745
2023
Q4
$378K Sell
2,782
-466
-14% -$63.3K 0.01% 749
2023
Q3
$397K Buy
3,248
+1,406
+76% +$172K 0.02% 688
2023
Q2
$234K Sell
1,842
-82
-4% -$10.4K 0.01% 903
2023
Q1
$249K Sell
1,924
-225
-10% -$29.1K 0.01% 843
2022
Q4
$282K Sell
2,149
-138
-6% -$18.1K 0.01% 735
2022
Q3
$267K Sell
2,287
-229
-9% -$26.7K 0.01% 686
2022
Q2
$296K Sell
2,516
-87
-3% -$10.2K 0.02% 639
2022
Q1
$339K Sell
2,603
-341
-12% -$44.4K 0.01% 713
2021
Q4
$449K Sell
2,944
-324
-10% -$49.4K 0.02% 606
2021
Q3
$529K Sell
3,268
-321
-9% -$52K 0.03% 519
2021
Q2
$588K Buy
3,589
+6
+0.2% +$983 0.03% 487
2021
Q1
$540K Sell
3,583
-767
-18% -$116K 0.03% 470
2020
Q4
$659K Buy
4,350
+3,134
+258% +$475K 0.05% 367
2020
Q3
$165K Sell
1,216
-2,324
-66% -$315K 0.06% 279
2020
Q2
$484K Buy
3,540
+937
+36% +$128K 0.04% 358
2020
Q1
$281K Buy
+2,603
New +$281K 0.03% 406
2019
Q1
Sell
-3,706
Closed -$359K 374
2018
Q4
$359K Buy
3,706
+1,859
+101% +$180K 0.07% 253
2018
Q3
$215K Buy
+1,847
New +$215K 0.04% 379
2017
Q1
Sell
-3,306
Closed -$297K 402
2016
Q4
$297K Buy
+3,306
New +$297K 0.06% 273